Mary S. Beattie

Internal Medicine

2356 Sutter St
San Francisco, CA 94115

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.

Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.

Journal: The Lancet. Oncology

Published: September 20, 2018

Reply to J.J. Tao et al.

Reply to J.J. Tao et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: June 02, 2018

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.

Targeted Therapy for Advanced Solid Tumors on the Basis of Molecular Profiles: Results From MyPathway, an Open-Label, Phase IIa Multiple Basket Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 11, 2018

NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer.

NatHER: protocol for systematic evaluation of trends in survival among patients with HER2-positive advanced breast cancer.

Journal: Systematic reviews

Published: May 22, 2015

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

Journal: PLoS genetics

Published: October 23, 2013

Genetic counseling, cancer screening, breast cancer characteristics, and general health among a diverse population of BRCA genetic testers.

Genetic counseling, cancer screening, breast cancer characteristics, and general health among a diverse population of BRCA genetic testers.

Journal: Journal of health care for the poor and underserved

Published: August 27, 2013

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

The SystHERs registry: an observational cohort study of treatment patterns and outcomes in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Journal: BMC cancer

Published: May 30, 2013

Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing.

Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing.

Journal: JAMA internal medicine

Published: December 19, 2012

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 13, 2012

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.

Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.

Journal: PLoS genetics

Published: September 07, 2012

Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.

Family communication of BRCA1/2 results and family uptake of BRCA1/2 testing in a diverse population of BRCA1/2 carriers.

Journal: Journal of genetic counseling

Published: August 28, 2012

Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California.

Comparison of age at natural menopause in BRCA1/2 mutation carriers with a non-clinic-based sample of women in northern California.

Journal: Cancer

Published: August 24, 2012

Showing 1-12 of 24

Last Updated: 09/26/2026